RxDoctor Payments DataLook up a doctor →

Nima Salari, MD

Orthopaedic Surgery of the Spine · Phoenix, AZNPI 1598967911

Payments from drug & device makers

$823,279in general payments, 2019–2025

Across 735 payments — averaging $1120.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medacta USA, Inc.$294K
  • Stryker$233K
  • Globus Medical$112K
  • Amplify Surgical, Inc.$85K
  • Omnia Medical, LLC$79K
  • Abbott$6K
  • plus $15K from 27 others
$5,250in research payments, 2019–2025

Across 11 payments — averaging $477.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intrinsic Therapeutics$3K
  • Additive Implants, Inc.$2K

What the payments were for

  • Royalty or licence$104,89314%
  • Consulting fees$465,03763%
  • Speaking & faculty fees$70,98910%
  • Travel & lodging$80,25311%
  • Food & beverage$19,4563%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$823,279 in reported general payments places this provider in the 90th percentile of 64 orthopaedic surgery of the spine providers in Arizona.

See all orthopaedic surgery of the spine providers in Arizona

Medicare billing

Part B allowed, 2024
$467,595
Medicare patients
543
Services billed
1,879

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib43$1,364
Gabapentin54$510
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$221
Methylprednisolone28$217
Oxycodone Hcl26$131
Cyclobenzaprine Hcl30$83
Meloxicam29$55

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →